Science Lead

Tom Zang

Tom Tsang, PhD

Co-inventor

-  PhD, University of Arizona - Microbiology, Immunology, Cancer Biology
-  Studied under Dr. Tim Bowden, Chief Science Officer, Arizona Cancer Center
-  40+ patents issued, 30+ research publications
    Areas: Cancer stem-cell fusion, Antibodies & Metabolic Targeting

In 2011, Dr. Tsang went to China to further develop The Warburg Way® protocol, training medical providers and serving as a liaison between patients and providers.

Business Lead

Val Rauluk

Valerie Rauluk

Founder, Venture Catalyst, Inc.

-  MBA, New York University, Stern School of Business
-  40+ years in technology development and financing
-  Health care, renewable energy, and computing
  Areas: investment banking, solar energy financing, more

In 2017, Ms. Rauluk began building the business infrastructure for global distribution of the TWW science and application, launching in palliative cancer care markets for patient populations currently abandoned by other treatments.